Skip to main content

Table 4 Association between separate endpoints survival and groups which divided by TyG in patients with plaque rupture

From: Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study

  Crude model Adjust model I Adjust model II Adjust model III
Group crude HR(95%CI) crude P value Adj I. HR(95%CI) Adj. P value Adj II. HR(95%CI) Adj. P value Adj III. HR(95%CI) Adj. P value
MACE         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 2.77 (0.74,10.46) 0.132 3.53 (0.88,14.25) 0.076 3.29 (0.74,14.68) 0.119 5.45 (1.1,27.09) 0.038*
 3 0.33 (0.03,3.13) 0.331 0.48 (0.05,4.78) 0.528 0.48 (0.04,5.25) 0.545 0.47 (0.04,4.95) 0.529
 Trend test 0.77 (0.38,1.55) 0.464 0.88 (0.41,1.87) 0.737 0.83 (0.36,1.92) 0.664 0.84 (0.38,1.89) 0.678
Revascularization         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 0.76 (0.28,2.04) 0.582 0.82 (0.29,2.33) 0.709 0.48 (0.15,1.51) 0.208 0.52 (0.16,1.73) 0.288
 3 0.98 (0.39,2.47) 0.967 1.13 (0.42,3.02) 0.806 0.56 (0.15,2.14) 0.398 0.64 (0.16,2.64) 0.540
 Trend test 0.99(0.612,1.60) 0.968 1.07 (0.65,1.78) 0.787 0.74 (0.37,1.49) 0.399 0.80 (0.38,1.66) 0.546
Angina         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 0.17 (0.02,1.37) 0.095 0.19 (0.02,1.65) 0.131 0.15 (0.02,1.42) 0.099 0.23 (0.02,2.37) 0.217
 3 1.01 (0.33,3.13) 0.987 1.23 (0.36,4.22) 0.737 1.02 (0.22,4.77) 0.980 2.92 (0.48,17.62) 0.242
 Trend test 1.01(0.52,1.96) 0.988 1.15 (0.57,2.31) 0.691 0.98 (0.41,2.32) 0.961 1.67 (0.64,4.34) 0.294
Bleeding events         
 1 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference) 1 (reference)
 2 1.09 (0.63,1.86) 0.765 1.1 (0.63,1.93) 0.728 1.12 (0.61,2.06) 0.713 1.15 (0.60,2.20) 0.669
 3 0.51 (0.27,0.97) 0.039* 0.47 (0.25,0.92) 0.027* 0.45 (0.20,0.98) 0.045* 0.45 (0.20,1.04) 0.062
 Trend test 0.74 (0.56,0.99) 0.045* 0.72 (0.53,0.97) 0.031* 0.71 (0.49,1.01) 0.060 0.70 (0.48,1.04) 0.075
  1. Data presented are HRs and 95% CI. Adjust I model adjusts for sex and age; Adjust II model adjusts for adjust I plus ejection fraction, smoke, hypertension, hyperlipidemia, diabetes mellitus; Adjust III model adjusts for adjust II + creatine kinase, heart rate and C-reactive protain
  2. Adj., adjusted; MACE, major adverse cardiovascular events; HR, hazard ratio; CI, confidence interval
  3. *P < 0.05